Author: Marketing User
-
The CIO’s Advantage: Faster Innovation with AI and Low Code
The CIO’s Advantage: Faster Innovation with AI and Low Code Reduce the time and coding expertise needed to build new apps and address your growing backlog of IT projects. Plus, customise and deploy AI agents that help you meet business needs more efficiently. Read The CIO’s Advantage: Faster Innovation with AI and Low Code to…
-
The AI Advantage: Driving sales performance with next-generation tools
The AI Advantage: Driving sales performance with next-generation tools From cutting down repetitive tasks to connecting data to continuously optimizing performance – AI helps sellers create momentum and crush sales. Read The AI Advantage to find out how AI supports sales teams throughout their day. You’ll learn how sellers use AI to eliminate inefficiencies and…
-
Automation’s Next Chapter
Automation’s Next Chapter Hospitals don’t need another primer on how to fix margin pressures or staffing gaps. The real question is how to take low-value work out of the system at scale, standardize decisions, and make results repeatable. Automation and AI are now practical levers for that work – moving from pilots to production across…
-
Unlock the power of your data with Generative AI
Unlock the power of your data with Generative AI The potential of generative AI in healthcare and life sciences is immense, yet its realization hinges on secure, structured access to quality data. Currently, up to 97% of hospital data remains underutilized due to being siloed, cumbersome to extract, or stored in inaccessible formats, posing significant…
-
Transforming Healthcare with Generative AI on AWS
Transforming Healthcare with Generative AI on AWS Generative artificial intelligence (AI) is revolutionizing healthcare by enhancing efficiency, accelerating innovation, and improving patient experiences. Amazon Web Services (AWS) offers a comprehensive set of solutions and tools designed to integrate generative AI into healthcare to enhance diagnostic accuracy, streamline clinical workflows, and improve patient outcomes. Explore how…
-
Reveleer Enhances Value-Based Care with AI-Powered Healthcare Analytics on AWS
Reveleer Enhances Value-Based Care with AI-Powered Healthcare Analytics on AWS Discover how our partnership with AWS is revolutionizing value-based care. Together, we’re empowering organizations to enhance quality and outcomes through intelligent automation. View the content on demand
-
AWS Life Sciences Symposium 2025 -Lilly
AWS Life Sciences Symposium 2025 -Lilly Even after access and harmonization, deriving insights from real world data can be a slow, technical process. That’s where Agents come in. Using a multi-agent ReAct framework, the agent enables researchers, analysts, and business users to query complex datasets using natural language. The result—actionable, auditable insights in minutes instead of weeks, with…
-
AWS Life Sciences Symposium 2025 Development Assistants at AstraZeneca
AWS Life Sciences Symposium 2025 Development Assistants at AstraZeneca AstraZeneca showcases its Development Assistant—an AI-powered, interactive agent that enables natural language access to its clinical trial data landscape, minimizes the need for custom application development, reduces costs, and accelerates insights. View the content on demand
-
AWS Life Sciences Symposium 2025 Keynote – Merck
AWS Life Sciences Symposium 2025 Keynote – Merck Learn how Merck Research Labs, showcases how they created a clinical data layer on AWS that brings together clinical and operational data across studies into a single platform, accelerating processes through purpose applications of automation. View the content on demand
-
AWS Life Sciences Symposium 2025 Keynote – Agentic AI for Life Sciences
AWS Life Sciences Symposium 2025 Keynote – Agentic AI for Life Sciences Today, 9 out of the top 10 global biopharma companies use AWS for generative AI, fueling innovations from advancing protein design, to accelerating clinical trial research, and reducing false rejects. Many of these life sciences leaders including Roche, Lilly, and AstraZeneca, are now…